Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Cerebral Small Vessel Disease
NCT05583266Phase 4Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Nov 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pentoxifylline in Cerebral Small Vessel Disease (CSVD), sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT05583266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583266.